Skip to Main Content
It looks like you're using Internet Explorer 11 or older. This website works best with modern browsers such as the latest versions of Chrome, Firefox, Safari, and Edge. If you continue with this browser, you may see unexpected results.

COVID-19 Feature Articles: Issue 85 December 23

A guide that lists selected articles regarding COVID-19 relevant to SVHA

COVID-19 Feature Articles

This page lists feature articles on COVID-19 relevant to people working at St Vincent's Health Australia.

All articles listed are open access unless stated otherwise.

Therapy

Efficacy and safety of COVID-19 convalescent plasma in hospitalized patients: a randomized clinical trial.
JAMA Internal Medicine:2021: December 13 
Full text

Antiplatelet therapy and outcome in COVID-19: the Health Outcome Predictive Evaluation Registry.
Heart:2021: October 5 Full text

Clinical Practice

Impact of the COVID-19 pandemic on hospital admissions of nursing home residents.
Australasian Journal on Ageing:2021: December 15 Full text

COVID-19 and geriatric medicine in Australia and New Zealand. AUS
Australasian Journal on Ageing:2021: December 13 Full text

Assessment of a hotel-based protective housing program for incidence of SARS-CoV-2 infection and management of chronic illness among persons experiencing homelessness.
JAMA Network Open:2021: December 13 Full text

Diagnosis

MRI and CT coronary angiography in survivors of COVID-19.
Heart:2021: December 10 Full text

Infection Control

Clinical accuracy and agreement between tympanic and forehead body temperature measurements for screening of patients with COVID-19.
Journal of Clinical Nursing:2021: December 15 Full text

Pathophysiology and Epidemiology

Global percentage of asymptomatic SARS-CoV-2 infections among the tested population and individuals with confirmed COVID-19 diagnosis: a systematic review and meta-analysis.
JAMA Network OPen:2021: December 14 Full text

The incubation period distribution of coronavirus disease 2019: a systematic review and meta-analysis.
Clinical Infectious Diseases:2021:73(12):2344-52 
Full text

Smoking and COVID-19 outcomes: an observational and Mendelian randomisation study using the UK Biobank cohort.
Thorax:2021: December 16  Full text

Long Covid

Long-term outcomes following severe COVID-19 infection: a propensity matched cohort study.
BMJ Open Respiratory Research:2021: December 9 Full text

Vaccines

Omicron-specific cytotoxic T-cell responses are boosted following a third dose of mRNA COVID-19 vaccine in anti-CD20-treated multiple sclerosis patients.
MedRxiv:2021:2021: December 21 Full text

Neutralization of SARS-CoV-2 Omicron variant by sera from BNT162b2 or Coronavac vaccine recipients.
Clinical Infectious Diseases:2021: December 16 Full text

Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection: test negative design study.
BMJ:2021: November 25 Full text

A Single mRNA vaccine dose in COVID-19 patients boosts neutralizing antibodies against SARS-CoV-2 and variants of concern.
Cell Reports Medicine:2021: December 14 Full text

Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection: test negative design study.
BMJ:2021: November 25 Full text

Effectiveness of mRNA-1273 against delta, mu, and other emerging variants of SARS-CoV-2: test negative case-control study.
BMJ:2021: December 15 Full text

Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study in Scotland and Brazil.
Lancet:2021: December 20 Full text

Humoral responses after SARS-CoV-2 mRNA vaccination and breakthrough infection in cancer patients.
Mayo Clinical Proceedings: Innovations, Quality and Outcomes:2021: December 13 Full text

Vaccine Adverse Effects

Newly diagnosed IgA nephropathy with gross haematuria following COVID-19 vaccination.
QJM:2021: December 1 Full text

SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study.
BMJ:2021: December 16 Full text

Immunology

Antibody response and variant cross-neutralization after SARS-CoV-2 breakthrough infection.
JAMA:2021: December 16 Full text

Evidence for increased SARS-CoV-2 susceptibility and COVID-19 severity related to pre-existing immunity to seasonal coronaviruses.
Cell Reports:2021: December 7 Full text

Pre-existing humoral immunity to human common cold coronaviruses negatively impacts the protective SARS-CoV-2 antibody response.
Cell Host and Microbe:2021: December 7 Full text

Chief Librarian - St Vincent's Hospital, Melbourne

Profile Photo
Jeremy Taylor
Contact:
03 9231 2542